eXoZymes, Inc. (EXOZ) vs Spectral AI, Inc. (MDAI)

A side-by-side comparison of eXoZymes, Inc. and Spectral AI, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

EXOZ

eXoZymes, Inc.

$51M

$5.54HealthcareDelayed quote: Oct 6, 2026, 11:59 AM EDT

MDAI

Spectral AI, Inc.

$54M

$1.69HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT

Total return — EXOZ vs MDAI

growth of $100 · dividends reinvested · last 2y

EXOZ -36.2% (-20.1%/yr)MDAI +25.2% (+11.9%/yr)MDAI compounded faster over this window

EXOZ MDAI

EXOZ vs MDAI: by the numbers

•MDAI is the larger company ($54M vs $51M market cap).
•Both run net losses; EXOZ's is the smaller (0.00% vs -69.27% net margin).

Metrics side by side

Valuation

Metric	EXOZ	MDAI
P/S ratio	N/A	3.54
P/B ratio	14.07	N/A

Profitability

Metric	EXOZ	MDAI
Gross margin	0.00%	41.51%
Operating margin	0.00%	-43.78%
Net margin	0.00%	-69.27%
ROE	-278.89%	N/A
ROIC	-157.40%	-353.68%

Growth (annualized)

Metric	EXOZ	MDAI
Total return CAGR (5Y)	N/A	-29.57%

Go deeper

Full EXOZ analysis Full MDAI analysis Interactive comparison tool

Dig into the metrics

eXoZymes ROE Spectral AI ROE eXoZymes operating margin Spectral AI operating margin eXoZymes revenue growth Spectral AI revenue growth eXoZymes free cash flow Spectral AI free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.